The ability to target the majority of human transcription factors remains an as yet unachieved goal in chemical biology and medicine. We developed a modular, synthetic transcriptional repressor platform that recapitulates the DNA-binding properties of native basic helix-loop-helix (bHLH) domains and can block the DNA-binding functions of an important oncogenic transcription factor target, MYC.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lambert, S. A. et al. The human transcription factors. Cell 172, 650–665 (2018). This review presents a global description of transcription factors in the human proteome.
Madden, S. K., de Araujo, A. D., Gerhardt, M., Fairlie, D. P. & Mason, J. M. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Mol. Cancer 20, 3 (2021). This review describes MYC in cancer and approaches to block activity.
Canne, L. E., Ferre-D’Amare, A. R., Burley, S. K. & Kent, S. B. H. Total chemical synthesis of a unique transcription factor-related protein: cMyc-Max. J. Am. Chem. Soc. 117, 2998–3007 (1995). This paper reports the first chemical synthesis of a bHLH heterodimer.
Talanian, R. V., McKnight, C. J. & Kim, P. S. Sequence-specific DNA binding by a short peptide dimer. Science 249, 769–771 (1990). This paper reports binding to DNA by a dimerized leucine zipper peptide.
Pajic, A. et al. Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. Int. J. Cancer 87, 787–793 (2000). This paper reports the modification of a B cell line for control of MYC expression.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Speltz, T. E. et al. Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domains. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01504-x (2022).
Rights and permissions
About this article
Cite this article
Synthetic biologics provide a path to target bHLH transcription factors. Nat Biotechnol 41, 480–481 (2023). https://doi.org/10.1038/s41587-022-01509-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-022-01509-6
